
doi: 10.1002/pds.946
pmid: 15170763
AbstractPurposeTo compare the relative risks of upper GI haemorrhage (UGIH) in users of Newer versus Older, non‐specific NSAIDs when adjusted for channelling bias by regression on individual covariates, a propensity score and both.MethodsCohort study of patients prescribed NSAIDs between June 1987 and January 2000. Exposure to Newer and Older non‐specific NSAIDs was identified, and risk factors evaluated for each patient. Results of multiple covariate analyses and the propensity scoring technique to assess potential channelling bias in comparisons between Newer and Older non‐specific NSAIDs were compared.ResultsThis study included 7.1 thousand patient years (tpy) exposure to meloxicam, 1.6 tpy exposure to coxibs, and 628 tpy exposure to Older non‐specific NSAIDs. Patients receiving Newer NSAIDs were older, more likely to have a history of GI symptoms, and at higher risk for GI complications. Adjusting for these risk factors reduced the relative risks of UGIH on meloxicam and coxibs versus Older non‐specific NSAIDs to 0.84 (95%CI 0.60, 1.17) and 0.36 (0.14, 0.97) respectively.ConclusionsChannelling towards high GI risk patients occurred in the prescribing of Newer NSAIDs. Propensity scores highlighted the markedly different risk profiles of users of Newer and Older non‐specific NSAID. Correcting for channelling bias, coxib exposure, but not meloxicam exposure, was associated with less UGIH than Older non‐specific NSAID exposure. In the present study, corrections made by regression on a propensity score and on individual covariates were similar. Copyright © 2004 John Wiley & Sons, Ltd.
Adult, Male, Propensity score, Databases, Factual, 610, Gastrointestinal haemorrhage, name=Pharmacology, Meloxicam, General practice research database, 618, Cohort Studies, Drug Utilization Review, Risk Factors, /dk/atira/pure/subjectarea/asjc/3000, Osteoarthritis, Coxibs, Humans, Cyclooxygenase Inhibitors, Aged, Aged, 80 and over, Pharmacoepidemiology, Nonsteroidal anti-inflammatory drugs, Anti-Inflammatory Agents, Non-Steroidal, Age Factors, Middle Aged, name=Pharmacology (medical), Toxicology and Pharmaceutics(all), /dk/atira/pure/subjectarea/asjc/2700/2736, Regression Analysis, Female, Family Practice, Gastrointestinal Hemorrhage
Adult, Male, Propensity score, Databases, Factual, 610, Gastrointestinal haemorrhage, name=Pharmacology, Meloxicam, General practice research database, 618, Cohort Studies, Drug Utilization Review, Risk Factors, /dk/atira/pure/subjectarea/asjc/3000, Osteoarthritis, Coxibs, Humans, Cyclooxygenase Inhibitors, Aged, Aged, 80 and over, Pharmacoepidemiology, Nonsteroidal anti-inflammatory drugs, Anti-Inflammatory Agents, Non-Steroidal, Age Factors, Middle Aged, name=Pharmacology (medical), Toxicology and Pharmaceutics(all), /dk/atira/pure/subjectarea/asjc/2700/2736, Regression Analysis, Female, Family Practice, Gastrointestinal Hemorrhage
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
